Location History:
- Hoostraten, BE (2011)
- Hoogstraten, BE (2009 - 2014)
Company Filing History:
3 out of 2,078 
1 out of 45 
1 out of 66 
Years Active: 2009-2014
Title: Innovator Paul Stoffels: Pioneering Advances in HIV Treatment
Introduction: Paul Stoffels, an accomplished inventor located in Hoogstraten, Belgium, has made significant contributions to the field of pharmaceutical science. With a remarkable portfolio consisting of five patents, his work primarily focuses on innovative treatments for HIV, aiming to enhance the therapeutic options available for this challenging disease.
Latest Patents: Among his latest inventions are notable patents that showcase his expertise. One such patent is titled "Combinations of a pyrimidine containing NNRTI with RT inhibitors." This invention addresses the therapeutic combination of a pyrimidine-containing non-nucleoside reverse transcriptase inhibitor (NNRTI) with nucleoside or nucleotide reverse transcriptase inhibitors. It is designed for the treatment of HIV-infected patients and for the prevention of HIV transmission. Another significant patent by Paul Stoffels is the "Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile." This patent encompasses a pharmaceutical composition that incorporates the hydrochloric acid salt of the named compound, alongside its preparation processes.
Career Highlights: Paul has had an impressive career in the pharmaceutical industry. He has played crucial roles at prominent companies such as Janssen Pharmaceutica NV and Janssen R&D Ireland. His efforts in these organizations have contributed to advancing HIV treatment regimens, marking him as a leading figure in pharmaceutical innovation.
Collaborations: Throughout his career, Paul has collaborated with esteemed colleagues, including Jérôme Emile Georges Guillemont and Paul Theodoor Agnes Stevens. These partnerships have fostered a creative environment that has led to groundbreaking developments in HIV research and treatment.
Conclusion: Paul Stoffels stands out as a pioneer in the field of HIV treatment, fueled by his innovative spirit and dedication to improving patient outcomes. His contributions, reflected in his patent portfolio, signify not only his expertise but also his commitment to combating one of the most pressing health challenges of our time.